rs61749567
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_032119.4(ADGRV1):c.1817A>C(p.Asn606Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00155 in 1,611,358 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. N606N) has been classified as Likely benign.
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADGRV1 | NM_032119.4 | c.1817A>C | p.Asn606Thr | missense_variant | 9/90 | ENST00000405460.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADGRV1 | ENST00000405460.9 | c.1817A>C | p.Asn606Thr | missense_variant | 9/90 | 1 | NM_032119.4 | P1 | |
ADGRV1 | ENST00000504142.2 | n.583A>C | non_coding_transcript_exon_variant | 3/14 | 5 | ||||
ADGRV1 | ENST00000640109.1 | n.1913A>C | non_coding_transcript_exon_variant | 9/9 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.00866 AC: 1317AN: 152120Hom.: 21 Cov.: 31
GnomAD3 exomes AF: 0.00218 AC: 537AN: 246804Hom.: 12 AF XY: 0.00163 AC XY: 219AN XY: 134202
GnomAD4 exome AF: 0.000810 AC: 1182AN: 1459120Hom.: 15 Cov.: 31 AF XY: 0.000708 AC XY: 514AN XY: 725936
GnomAD4 genome ? AF: 0.00868 AC: 1321AN: 152238Hom.: 21 Cov.: 31 AF XY: 0.00802 AC XY: 597AN XY: 74416
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jun 04, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jan 24, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 23, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 30, 2012 | Asn606Thr in Exon 09 of GPR98: This variant is not expected to have clinical sig nificance because it has been identified in 3.2% (96/2992) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs61749567). - |
Febrile seizures, familial, 4;C2931213:Usher syndrome type 2C Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 08, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at